Pfizer donates COVID-19 treatment drugs worth USD 70 million to India

By Nikita Chaurasia  Date: 2021-05-04

Pfizer donates COVID-19 treatment drugs worth USD 70 million to India

Reportedly, American multinational pharmaceutical firm Pfizer Inc. has extended a helping hand to India in the battle against Covid-19, sending drugs worth USD 70 million to the country. The company is also in discussion with the Indian government to initiate an accelerated approval pathway to make its vaccines available for use in India.

Commenting on the move, Albert Bourla, CEO and Chairman at Pfizer, mentioned they are aware of how critical access to vaccines is to end this pandemic. Their vaccine is not registered in India though they had submitted the application months ago, he added.

Last month, the pharmaceutical giant offered the Indian government's immunization program a non-profit price for its COVID-19 vaccine.

A Pfizer spokesperson expressed they are in talks with the government and remain committed to making their vaccine available for use in India. The drugmaker also stated that its top priority is to help governments solely by providing its vaccine to them for their immunization programs.

It is worth noting that after failing to meet the drug regulator's demand for a local safety and immunogenicity review, the company withdrew an application for emergency-use authorization (EUA) of its COVID-19 vaccine in India in February.

However, the government recently renounced the obligation of presenting local bridge trial data upfront for vaccines permitted by the European Medicines Agency (EMA), UK MHRA, USFDA, or those listed with the WHO under Emergency Use Listing. The pharmaceutical firm is now entitled to seek EUA directly from the DCGI (Drugs Controller General of India) to import its COVID-19 vaccine.

The company is deeply concerned about the grave COVID-19 situation in India, and their hearts go out to all Indians, Bourla wrote in an email he posted on his LinkedIn page, sources confirmed.

The company would be sending drugs worth USD 70 million (over Rs 510 crore) to India from its distribution centers in Asia, Europe, and the United States, according to Bourla's email.

Source Credit –

https://www.moneycontrol.com/news/business/pfizer-donates-70-million-worth-covid-19-treatment-drugs-to-india-6848131.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Apple unveils 16-inch MacBook Pro with high-performance M1 processors

Apple unveils 16-inch MacBook Pro with high-performance M1 processors

By Nikita Chaurasia

Tech giant Apple, Inc. has recently unveiled the 16-inch MacBook Pro, which promises extraordinary design and performance. The model can be customized with the all-new M1 Pro and M1 Max processors.    These new 10-core processors are ...

Kedrion Biopharma expands to North America with Prometic acquisition

Kedrion Biopharma expands to North America with Prometic acquisition

By Nikita Chaurasia

Prometic Life Sciences has developed the first FDA-approved treatment for Congenital Plasminogen Deficiency. This acquisition will enable easy access to advanced therapies for patients suffering from this rare disease. Kedrion Biopharma Inc. has...

Facebook Pages to reduce focus on Likes and followers for Indian users

Facebook Pages to reduce focus on Likes and followers for Indian users

By Nikita Chaurasia

Facebook Inc. has reportedly removed Likes from Facebook Pages for its Indian users to make the platform more user-friendly and easier to understand. This redesign of Facebook Pages was launched in January 2021 and has been rolled out for Indian user...

Merchant commerce platform Pine Labs eyeing USD 1 Bn Nasdaq listing

Merchant commerce platform Pine Labs eyeing USD 1 Bn Nasdaq listing

By Nikita Chaurasia

India is likely to witness a record number of IPOs this year, with several companies eyeing public listing to raise funds if the market sentiment remains positive. One such company, Pine Labs is reportedly planning to list itself on Nasdaq by October...

European climate group asks EU for tougher CO2 targets for truck makers

European climate group asks EU for tougher CO2 targets for truck makers

By Nikita Chaurasia

According to a recent study conducted by Europe’s Transport and Environment (T&E), the European Union (EU) should implement stricter CO2 targets for truck makers to swiftly transition to zero-emission models as present goals do not provide ...